Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07248144 in Advanced Solid Tumors
NCT04606446Phase 2Recruiting
- Sponsor
- Pfizer
- Start
- Nov 2020
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of prifetrastat in breast cancer, castration-resistant prostate cancer (CRPC), non-small cell lung cancer (NSCLC), sponsored by Pfizer. Started Nov 2020; status: recruiting.
02
Drugs
prifetrastat
03
Conditions
breast cancercastration-resistant prostate cancer (CRPC)non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04606446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04606446.